MedPath

TRIAMINIC DM+DECONGESTANT LIQUI-GELS CAPSULES

TRIAMINIC DM+DECONGESTANT LIQUI-GELS CAPSULES

Discontinued
DIN Number

02039753

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

Sandoz Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02039753
AIG Number0214697006
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05DA20 COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DEXTROMETHORPHAN HYDROBROMIDEActive
Strength: 15 MG / CAP
Monograph: DEXTROMETHORPHAN HYDROBROMIDE
PSEUDOEPHEDRINE HYDROCHLORIDEActive
Strength: 30 MG / CAP
Monograph: PSEUDOEPHEDRINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.